Everything to do with second medical use patents.
Not because of any fault in the legal reasoning: because the decision came to be made by a Court at all.
If you haven’t yet had a chance to read the Pregabalin Judgment then you can save yourself some time by reading this excellent summary by Darren Smyth of EIP.
This article isn’t going to re-tread any ground. It’s about whether the law relating to second medical use patents is fit for purpose, and whether a Court should really be making these assessments, Supreme or not.
The reason you should care about patenting new uses for existing drugs, even if you’re not a patent lawyer, is because it is the future of healthcare.… Read more...